Skin lesion's treatment with alfa interferon in a patient with B-CLL.
Treatment with recombinant alfa-2b-interferon in a patient with advanced B-CLL resulting in complete remission of skin lesions after one month therapy is reported in this paper. Interferon was administered subcutaneously three times weekly. Six months later while the treatment continued, the disease remained stable.
Panteli
K
K
Haematology Unit, Medical School, University of Ioannina, Greece.
Katsanos
K H
KH
Kitsanou
M
M
Nakou
K
K
Alexandridis
G
G
Bourantas
K L
KL
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D011994:Recombinant Proteins; D012074:Remission Induction; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins